[Hantavirus mucosal vaccine through different mucosal with heat-labile enterotoxin B subunit as adjuvants]
[Article in Chinese]
Cao SC,
Li JD,
Lu P,
Liu F,
Wang Q,
Liu QZ,
Zhang QF,
Li C,
An Q,
Liang MF,
Li DX.
State Key Laboratory for Infectious Disease Control and Prevention, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China.
OBJECTIVE: To evaluation the effect of different mucosal vaccination pathway on hantavirus with the recombinant E. coli heat-labile enterotoxin B subunit (rLTB) as adjuvant. METHODS: The rLTB was expressed and purified. Take the inactivated hantavirus strain 84Fli as vaccine, and immunized C57 BL/6 mice through intranasal, oral and vaginal respectively. Specific IgG and sectory IgA were detected by ELISA in serum, and vaginal washing samples respectively. RESULTS: The rLTB was efficiently expressed under the induction of lactose, identified by western blotting and GM-1 binding experiment. The vaccination through intranasal, oral and vaginal, can induce IgG and sectory IgA response. CONCLUSION: Inactivated hantavirus can produce mucosal immune response with rLTB as adjuvants through intranasal, oral and vaginal vaccination respectively.
PMID: 19031694 [PubMed - indexed for MEDLINE]